Predicting synthetic lethal interactions in human cancers using graph regularized self-representative matrix factorization

Synthetic lethality has attracted a lot of attentions in cancer therapeutics due to its utility in identifying new anticancer drug targets. Identifying synthetic lethal (SL) interactions is the key step towards the exploration of synthetic lethality in cancer treatment. However, biological experiments are faced with many challenges when identifying synthetic lethal interactions. Thus, it is necessary to develop computational methods which could serve as useful complements to biological experiments. In this paper, we propose a novel graph regularized self-representative matrix factorization (GRSMF) algorithm for synthetic lethal interaction prediction. GRSMF first learns the self-representations from the known SL interactions and further integrates the functional similarities among genes derived from Gene Ontology (GO). It can then effectively predict potential SL interactions by leveraging the information provided by known SL interactions and functional annotations of genes. Extensive experiments on the synthetic lethal interaction data downloaded from SynLethDB database demonstrate the superiority of our GRSMF in predicting potential synthetic lethal interactions, compared with other competing methods. Moreover, case studies of novel interactions are conducted in this paper for further evaluating the effectiveness of GRSMF in synthetic lethal interaction prediction. In this paper, we demonstrate that by adaptively exploiting the self-representation of original SL interaction data, and utilizing functional similarities among genes to enhance the learning of self-representation matrix, our GRSMF could predict potential SL interactions more accurately than other state-of-the-art SL interaction prediction methods.

[1]  R. Ophir,et al.  Prediction of high risk Ewing's sarcoma by gene expression profiling , 2004, Oncogene.

[2]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[3]  P. Hieter,et al.  Synthetic lethality and cancer , 2017, Nature Reviews Genetics.

[4]  Thomas Horn,et al.  GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update , 2012, Nucleic Acids Res..

[5]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[6]  A. Giaccia,et al.  Harnessing synthetic lethal interactions in anticancer drug discovery , 2011, Nature Reviews Drug Discovery.

[7]  Elizabeth Iorns,et al.  A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor , 2008, The EMBO journal.

[8]  L. Hartwell,et al.  Integrating genetic approaches into the discovery of anticancer drugs. , 1997, Science.

[9]  S. Nijman Synthetic lethality: General principles, utility and detection using genetic screens in human cells , 2011, FEBS letters.

[10]  Chee Keong Kwoh,et al.  Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..

[11]  Fan Zhang,et al.  In Silico Prediction of Synthetic Lethality by Meta-Analysis of Genetic Interactions, Functions, and Pathways in Yeast and Human Cancer , 2014, Cancer informatics.

[12]  Erkki Oja,et al.  Unified Development of Multiplicative Algorithms for Linear and Quadratic Nonnegative Matrix Factorization , 2011, IEEE Transactions on Neural Networks.

[13]  Hui Liu,et al.  SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets , 2015, Nucleic Acids Res..

[14]  Kara Dolinski,et al.  The BioGRID interaction database: 2017 update , 2016, Nucleic Acids Res..

[15]  Yong Liu,et al.  SL2MF: Predicting Synthetic Lethality in Human Cancers via Logistic Matrix Factorization , 2018, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[16]  B. Garvik,et al.  Principles for the Buffering of Genetic Variation , 2001, Science.

[17]  Lei S. Qi,et al.  Genetic interaction mapping in mammalian cells using CRISPR interference , 2017, Nature Methods.

[18]  Eytan Ruppin,et al.  Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality , 2014, Cell.

[19]  Subarna Sinha,et al.  Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data , 2017, Nature Communications.

[20]  Fan Zhang,et al.  Syn-Lethality: An Integrative Knowledge Base of Synthetic Lethality towards Discovery of Selective Anticancer Therapies , 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine.

[21]  Feng Luo,et al.  Understanding and predicting synthetic lethal genetic interactions in Saccharomyces cerevisiae using domain genetic interactions , 2011, BMC Systems Biology.

[22]  Philip S. Yu,et al.  A new method to measure the semantic similarity of GO terms , 2007, Bioinform..

[23]  Gaelen T. Hess,et al.  Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions , 2017, Nature Biotechnology.

[24]  H. Bussey,et al.  Exploring genetic interactions and networks with yeast , 2007, Nature Reviews Genetics.

[25]  P. Brown,et al.  Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data , 2014, Breast Cancer Research and Treatment.

[26]  Xuelong Li,et al.  Self-Representative Manifold Concept Factorization with Adaptive Neighbors for Clustering , 2018, IJCAI.

[27]  Michael J. Emanuele,et al.  A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene , 2009, Cell.

[28]  Y. Oron,et al.  Establishment of a chemical synthetic lethality screen in cultured human cells. , 2001, Genome research.